Martin, A.J.; Shackleford, D.M.; Charman, S.A.; Wagstaff, K.M.; Porter, C.J.H.; Jans, D.A.
Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus. Pharmaceutics 2023, 15, 1974.
https://doi.org/10.3390/pharmaceutics15071974
AMA Style
Martin AJ, Shackleford DM, Charman SA, Wagstaff KM, Porter CJH, Jans DA.
Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus. Pharmaceutics. 2023; 15(7):1974.
https://doi.org/10.3390/pharmaceutics15071974
Chicago/Turabian Style
Martin, Alexander J., David M. Shackleford, Susan A. Charman, Kylie M. Wagstaff, Christopher J. H. Porter, and David A. Jans.
2023. "Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus" Pharmaceutics 15, no. 7: 1974.
https://doi.org/10.3390/pharmaceutics15071974
APA Style
Martin, A. J., Shackleford, D. M., Charman, S. A., Wagstaff, K. M., Porter, C. J. H., & Jans, D. A.
(2023). Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus. Pharmaceutics, 15(7), 1974.
https://doi.org/10.3390/pharmaceutics15071974